Table 2.
Clinical trials related to Treg and kidney transplantation that are ongoing
| Study | Status | Location |
|---|---|---|
| Treg adoptive therapy for subclinical inflammation in kidney transplantation (43) | Active, not recruiting | University of California, San Francisco, California |
| Treg therapy in subclinical inflammation in kidney transplantation (44) | Recruiting | University of Alabama at Birmingham, Birmingham, Alabama |
| Cedars-Sinai Medical Center, Los Angeles, California | ||
| University of California, San Francisco, San Francisco, California | ||
| (and three more...) | ||
| Rapamycin and regulatory T cells in kidney transplantation (45) | Completed | Policlinico Fondazione IRCCS “San Matteo,” Pavia, Italy |
| Infusion of T-Regulatory cells in kidney transplant recipients (The ONE Study) (46) | Active, not recruiting | Massachusetts General Hospital Boston, Massachusetts |
| A pilot study using autologous regulatory T cell infusion zortress (Everolimus) in renal transplant recipients (47) | Not yet recruiting | University of Kentucky Medical Center Lexington, Kentucky |
| Effect of different therapeutic strategies on regulatory T cells in kidney transplantation (48) | Completed | Policlinico Fondazione IRCCS “San Matteo” Pavia, Italy |
| Donor-alloantigen-reactive regulatory T cell (darTreg) therapy in renal transplantation (The ONE Study) (49) | Recruiting | University of California San Francisco - Transplant Department, San Francisco, California |
| Effects of sevoflurane and desflurane on Treg (50) | Completed | Ramathibodi Hospital, Ratchathewi, Bangkok, Thailand |
| Trial of adoptive immunotherapy with TRACT to prevent rejection in living donor kidney transplant recipients (51) | Active, not recruiting | Northwestern University Comprehensive Transplant Center, Chicago, Illinois |
| Role of T helper 17 and regulatory T cells in delayed graft function (52) | Active, not recruiting | McGill University Health Center, Montreal, Quebec, Canada |
| Ultra-low-dose subcutaneous IL-2 in renal transplantation (53) | Active, not recruiting | Brigham and Women’s Hospital, Boston |
| The differential effects of 3 different immunosuppressive (54) | Completed | Northwestern Memorial Hospital, Chicago, Illinois |
TRACT, T-reg Adoptive Cell Transfer.